Primus pH Probe: Smaller, Minimally Invasive Device Innovative acid reflux test debuts micro sensor.
San Diego, California, USA – January 19, 2012 – Today, Respiratory Technology Corporation (Restech) announced the launch of its Primus Probe for the Dx-pH Measurement System™, adding to the world's first and only system for monitoring real-time aerosolized pH currently used throughout the United States and in thirty countries worldwide.
With a 25% smaller tip and softer polymer catheter than the standard Restech Dx-pH Probe, the Primus is ideal for patients who are more sensitive or have less nasopharyngeal clearance. The tip of the probe is less than 2.4 millimeters in diameter and the smooth, flexible catheter allows for easy insertion through a small naris.
Visual placement in the oropharynx guided by a blinking LED eliminates the need for manometry, fluoroscopy, or x-ray. Because it sits comfortably in the airway, the Primus Probe does not interfere with speaking or swallowing while the patient continues with his or her normal daily routine.
Linda Brodsky, MD, says, “The Primus Probe is very easy to insert, seems comfortable for the patients and is very well tolerated in the pediatric population.” Dr. Brodsky specializes in Pediatric Otolaryngology and is the author of over 100 professional publications and two books in this field.
Recognizing reflux disorders as a rapidly growing health concern in the western world, Restech CEO Leo Roucher assures, “Our team develops pioneering technologies to enhance test sensitivity while miniaturizing size and minimizing invasiveness. Our goal is improvement of patient comfort and compliance while adding ease and simplicity for the clinical staff.”
The Dx–pH Measurement System is a revolutionary system that comfortably measures pH in the airway.
Gastric reflux in the upper airway, or laryngopharyngeal reflux, commonly takes a gaseous form which is difficult to measure. The small pH sensor at the tip of the probe is unique in its ability to measure pH in a non-liquid environment, such as the oropharynx. By monitoring the pH levels in the pharynx, the Dx–System enables physicians to assess presence of laryngopharyngeal reflux and evaluate it as a possible contributor to their patients’ symptoms.
The Dx-pH Probe and Primus Probe house a micro sensor at the end of a catheter. The probe is placed posterior to the uvula in the oropharynx. Because it sits high in the airway, swallowing and speaking are not impeded. The small size and minimally invasive position allow patients to carry on normal, everyday activities including eating, talking, and sleeping with more comfort than conventional esophageal pH probes.
The measurements taken by the pH sensor is sent wirelessly to a recording device which the patient carries throughout the study period. Upon completion of the study (usually 24 hours), the patient returns to the physician’s office where the data is downloaded and presented graphically for analysis using Restech’s custom DataView™ software.
Restech is a leader in engineering world class medical technologies that provide comfortable solutions to assist physicians in the diagnosis of reflux related health problems quickly and reliably.
The innovative engineering team at Restech is led by professionals with extensive experience in medical device development. Together, the Restech staff holds over thirty patents in the areas of sensor technology, monitoring systems, and medical devices.
For more information on the Dx-pH Measurement System, please Call 800.352.1512 or visit www.restech.com.